These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 14225293)
1. [FOODS-DRUGS-POISONS. ELEMENTS OF DEFINITION]. TREMOLIERES J J Med Chir Prat; 1964 Oct; 135():339-47. PubMed ID: 14225293 [No Abstract] [Full Text] [Related]
2. Drugs on the market. JAMA; 1970 Feb; 211(7):1177. PubMed ID: 5466970 [No Abstract] [Full Text] [Related]
3. New names for drugs: what is USAN? Andrako J JAMA; 1977 May; 237(22):2413-4. PubMed ID: 576948 [No Abstract] [Full Text] [Related]
4. FDA holds public meeting on nanotechnology. Traynor K Am J Health Syst Pharm; 2006 Nov; 63(22):2175-7. PubMed ID: 17090732 [No Abstract] [Full Text] [Related]
6. Similar drug names a risky prescription. Hampton T JAMA; 2004 Apr; 291(16):1948-9. PubMed ID: 15113794 [No Abstract] [Full Text] [Related]
7. Editorial: Standardization of drug names. Lewis JR JAMA; 1974 Jul; 229(5):559-60. PubMed ID: 4406902 [No Abstract] [Full Text] [Related]
8. ADVERSE DRUG REACTION REPORTING AND THE RELATED ESTABLISHMENT OF A REGISTRY OF TISSUE REACTIONS TO DRUGS. WESTON JK Med Ann Dist Columbia; 1965 Aug; 34():380-2. PubMed ID: 14338452 [No Abstract] [Full Text] [Related]
9. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA. WESTON JK; WESTON K Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685 [No Abstract] [Full Text] [Related]
10. Standardization of drug names. Allan FM JAMA; 1974 Jul; 229(5):541-3. PubMed ID: 4406898 [No Abstract] [Full Text] [Related]
11. Toxicity and primary irritation of some chemical compounds following oral administration and skin application. DRAIZE JH; ALVAREZ E; WHITESELL MF Fed Proc; 1946; 5(1 Pt 2):174. PubMed ID: 21064303 [No Abstract] [Full Text] [Related]
12. Medication errors caused by confusion of drug names. Hoffman JM; Proulx SM Drug Saf; 2003; 26(7):445-52. PubMed ID: 12735783 [TBL] [Abstract][Full Text] [Related]
13. [Technical studies & exactness on tissular & cellular localization of drugs & poisons]. MASCHERPA P J Med Bord; 1957 May; 134(5):671-4. PubMed ID: 13449466 [No Abstract] [Full Text] [Related]
14. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs. Friedman JM Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499 [No Abstract] [Full Text] [Related]
15. Why is it called that? tongue-twisting taxonomy. Wick JY Consult Pharm; 2011 Aug; 26(8):544-52. PubMed ID: 21840818 [TBL] [Abstract][Full Text] [Related]
16. When names make claims: ethical issues in medical device marketing. Bramstedt KA Ethics Med; 2004; 20(2):47-57. PubMed ID: 15468483 [No Abstract] [Full Text] [Related]
18. Change in FDA definition of serious adverse drug event. Bader RL Am J Hosp Pharm; 1989 Jun; 46(6):1132. PubMed ID: 2750762 [No Abstract] [Full Text] [Related]
19. [Destined for medicinal substances in the body; Interpretation of the differences in toxicity of poisons injected by the intramuscular and intravenous routes]. LEVY J Bull Soc Chim Biol (Paris); 1945; 27():584-96. PubMed ID: 21027595 [No Abstract] [Full Text] [Related]
20. The drug regulatory system of the United States Food and Drug Administration: a defense of current requirements for safety and efficacy. Simmons HE Int J Health Serv; 1974; 4(1):95-107. PubMed ID: 4829901 [No Abstract] [Full Text] [Related] [Next] [New Search]